A volatile time for British drug policies: commentary on the editorial by Alan Glanz.
Stimson
G V
GV
Donoghoe
M
M
Dolan
K
K
Alldritt
L
L
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D006291:Health Policy / Q000639:trends*; D006556:Heroin Dependence / Q000150:complications* / Q000517:prevention & control; D006801:Humans; D012307:Risk Factors; D006113:United Kingdom